Just found out reverse split will be 14 to 1, per Merrill Lynch.
Going on 20 years and a BILLION dollars down the drain, this company is doing yet another reverse split so they can run the stock up and do another PIPE deal to pay their bloated salaries. Not impressed. Short now and cover when the PIPE is announced .... and trust me it WILL BE.
They plan on raising $25M or, with discounted share pricing, 2X the current market cap. Anyone owning shares will see their stake in the company drop to 1/3 of the current pct. Due to past bad management they really don't have a choice but, does it ever suck to be a CLSN shareholder
CLSN -- Buy more or sell what I got.?????
The five grand i paid for this stock a couple years ago is now worth 168 dollars. It will be a write off for this year.
Any news about earnings??
I think CLSN is due for a pullback. What are your thoughts? Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from a.awesomestocks.
Deregulation executive order coming for bio? Would this stock pop then?
Drop CLSN and put it on watchlist for now. R/S will likely occur this year it was put to vote already. NVAX may be more interesting.
recently received classic line cold call pitch - "we once discussed celsion, today I want to introduce you to a real company"
Are the chances of CLSN meeting it's Q1 estimates pretty good?
What is RS?
they'll run it up to 60 cents for the RS , get max bang for the shorts once it RS's .... they want to RS it as high as possible so the shorting makes huge profits
Wish the 21stCCA & THE SBIR would get involved!!!!!
The study was conducted under a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) to evaluate whether ThermoDox® combined with mild heating of the bladder can target drug delivery in the bladder.
The NIH studies were conducted under the direction of Dr. Bradford Wood, MD, Director, NIH Center for Interventional Oncology and Chief, NIH Clinical Center Interventional Radiology
WISHES FOR HORSES,,, OR MAYBE NOT !!!!!
Celsion Corporation Reports Preclinical Results of ThermoDox® for the Treatment of Bladder Cancer Published in the International Journal of Hyperthermia
Higher Concentrations of Doxorubicin Accumulation and Distribution within the Bladder Wall Were Achieved with ThermoDox ® Combined with Mild Local Hyperthermia Compared to Free Doxorubicin Alone. The Study ...
CLSN - hsbc trading showing 1.50 target price? Adding to watchlist. Not familar with this one but chart shows potential.
CBLI Cleveland BioLabs, Inc. 4.80 3.24 207.69%
Well MT...Time to pull the partnership out of your hat...The one you've been hinting at for years...What happened to those "chills" you mentioned you were getting from the read-outs? Are you in cahoots with your banker friends? Pushing to a R/S? Do they have you by the B@%!&? Have you called the SEC like any good CEO would do? Complaining about the naked shorting! Time to put up or...You know the rest...
NEXT BUYOUT TARGET HERE AQSZF (MC $15 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $15 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .
Market Cap :US$ 15 Million Cash $4.1 Million << enough untill mid 2018 Price 0.21
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.6 In other words, the correlation coefficient of the other stoc